Distinct Embryonic Expression and Localization of CBP and p300 Histone Acetyltransferases at the Mouse αA-Crystallin Locus in Lens

Journal of Molecular Biology

Volumn 369, Issue 4, 2007, Pages 917-926

  Yang, Ying ^a   Wolf, Louise V ^a   Cvekl, Ales ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

CBP p300; chromatin; crystallin; histone acetylation; lens

Indexed keywords

ALPHA CRYSTALLIN; HISTONE ACETYLTRANSFERASE;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYO; EPITHELIUM CELL; GENE EXPRESSION; IN VIVO STUDY; LENS; MOUSE; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN STRUCTURE; STATISTICAL SIGNIFICANCE;

MAMMALIA;

EID: 34249038355     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.04.004     Document Type: Article

References (60)

1. Wu C. Chromatin remodeling and the control of gene expression. J. Biol. Chem. 272 (1997) 28171-28174
2. Horn P.J., and Peterson C.L. Molecular biology. Chromatin higher order folding-wrapping up transcription. Science 297 (2002) 1824-1827
3. Workman J.L., and Kingston R.E. Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu. Rev. Biochem. 67 (1998) 545-579
4. de la Serna I.L., Ohkawa Y., and Imbalzano A.N. Chromatin remodelling in mammalian differentiation: lessons from ATP-dependent remodellers. Nature Rev. Genet. 7 (2006) 461-473
5. Fischle W., Wang Y., and Allis C.D. Histone and chromatin cross-talk. Curr. Opin. Cell Biol. 15 (2003) 172-183
6. Nightingale K.P., O'Neill L.P., and Turner B.M. Histone modifications: signalling receptors and potential elements of a heritable epigenetic code. Curr. Opin. Genet. Dev. 16 (2006) 125-136
7. Marmorstein R. Structure of histone acetyltransferases. J. Mol. Biol. 311 (2001) 433-444
8. Muchardt C., and Yaniv M. ATP-dependent chromatin remodelling: SWI/SNF and Co. are on the job. J. Mol. Biol. 293 (1999) 187-198
9. de la Cruz X., Lois S., Sanchez-Molina S., and Martinez-Balbas M.A. Do protein motifs read the histone code?. BioEssays 27 (2005) 164-175
10. Fan H.Y., He X., Kingston R.E., and Narlikar G.J. Distinct strategies to make nucleosomal DNA accessible. Mol. Cell 11 (2003) 1311-1322
11. Peterson C.L., and Workman J.L. Promoter targeting and chromatin remodeling by the SWI/SNF complex. Curr. Opin. Genet. Dev. 10 (2000) 187-192
12. Cosma M.P. Ordered recruitment: gene-specific mechanism of transcription activation. Mol. Cell 10 (2002) 227-236
13. Bloemendal H., de Jong W., Jaenicke R., Lubsen N.H., Slingsby C., and Tardieu A. Ageing and vision: structure, stability and function of lens crystallins. Prog. Biophys. Mol. Biol. 86 (2004) 407-485
14. Bhat S.P. Crystallins, genes and cataract. Prog. Drug Res. 60 (2003) 205-262
15. Wistow G.J., and Piatigorsky J. Lens crystallins: the evolution and expression of proteins for a highly specialized tissue. Annu. Rev. Biochem. 57 (1988) 479-504
16. Robinson M.L., and Overbeek P.A. Differential expression of alpha A- and alpha B-crystallin during murine ocular development. Invest. Ophthalmol. Vis. Sci. 37 (1996) 2276-2284
17. Yang Y., Stopka T., Golestaneh N., Wang Y., Wu K., Li A., et al. Regulation of alphaA-crystallin via Pax6, c-Maf, CREB and a broad domain of lens-specific chromatin. EMBO J. 25 (2006) 2107-2118
18. Cvekl A., Kashanchi F., Sax C.M., Brady J.N., and Piatigorsky J. Transcriptional regulation of the mouse alpha A-crystallin gene: activation dependent on a cyclic AMP-responsive element (DE1/CRE) and a Pax-6-binding site. Mol. Cell Biol. 15 (1995) 653-660
19. Yang Y., and Cvekl A. Tissue-specific regulation of the mouse alphaA-crystallin gene in lens via recruitment of Pax6 and c-Maf to its promoter. J. Mol. Biol. 351 (2005) 453-469
20. Kantorow M., Cvekl A., Sax C.M., and Piatigorsky J. Protein-DNA interactions of the mouse alpha A-crystallin control regions. Differences between expressing and non-expressing cells. J. Mol. Biol. 230 (1993) 425-435
21. Yang Y., and Cvekl A. Large Maf transcription factors: cousins of AP-1 proteins and important regulators of cellular differentiation. Einstein J. Biol. Med. 23 (2007) 2-11
22. Chen Q., Dowhan D.H., Liang D., Moore D.D., and Overbeek P.A. CREB-binding protein/p300 co-activation of crystallin gene expression. J. Biol. Chem. 277 (2002) 24081-24089
23. Chen Q., Liang D., Fromm L.D., and Overbeek P.A. Inhibition of lens fiber cell morphogenesis by expression of a mutant SV40 large T antigen that binds CREB-binding protein/p300 but not pRb. J. Biol. Chem. 279 (2004) 17667-17673
24. Eckner R., Ewen M.E., Newsome D., Gerdes M., DeCaprio J.A., Lawrence J.B., and Livingston D.M. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8 (1994) 869-884
25. Chrivia J.C., Kwok R.P., Lamb N., Hagiwara M., Montminy M.R., and Goodman R.H. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365 (1993) 855-859
26. Goodman R.H., and Smolik S. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14 (2000) 1553-1577
27. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., and Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87 (1996) 953-959
28. Bannister A.J., and Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature 384 (1996) 641-643
29. Kundu T.K., Palhan V.B., Wang Z., An W., Cole P.A., and Roeder R.G. Activator-dependent transcription from chromatin in vitro involving targeted histone acetylation by p300. Mol. Cell 6 (2000) 551-561
30. Gu W., and Roeder R.G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90 (1997) 595-606
31. van Genderen M.M., Kinds G.F., Riemslag F.C., and Hennekam R.C. Ocular features in Rubinstein-Taybi syndrome: investigation of 24 patients and review of the literature. Br. J. Ophthalmol. 84 (2000) 1177-1184
32. Hennekam R.C., Van Den Boogaard M.J., Sibbles B.J., and Van Spijker H.G. Rubinstein-Taybi syndrome in The Netherlands. Am. J. Med. Genet. Suppl. 6 (1990) 17-29
33. Yao T.P., Oh S.P., Fuchs M., Zhou N.D., Ch'ng L.E., Newsome D., et al. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93 (1998) 361-372
34. Kung A.L., Rebel V.I., Bronson R.T., Ch'ng L.E., Sieff C.A., Livingston D.M., and Yao T.P. Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. Genes Dev. 14 (2000) 272-277
35. Partanen A., Motoyama J., and Hui C.C. Developmentally regulated expression of the transcriptional cofactors/histone acetyltransferases CBP and p300 during mouse embryogenesis. Int. J. Dev. Biol. 43 (1999) 487-494
36. Kasper L.H., Fukuyama T., Biesen M.A., Boussouar F., Tong C., de Pauw A., et al. Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development. Mol. Cell Biol. 26 (2006) 789-809
37. Kalkhoven E. CBP and p300: HATs for different occasions. Biochem. Pharmacol. 68 (2004) 1145-1155
38. Barrera L.O., and Ren B. The transcriptional regulatory code of eukaryotic cells-insights from genome-wide analysis of chromatin organization and transcription factor binding. Curr. Opin. Cell. Biol. 18 (2006) 291-298
39. Heintzman N.D., Stuart R.K., Hon G., Fu Y., Ching C.W., Hawkins R.D., et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nature Genet. 39 (2007) 311-318
40. Lee C.K., Shibata Y., Rao B., Strahl B.D., and Lieb J.D. Evidence for nucleosome depletion at active regulatory regions genome-wide. Nature Genet. 36 (2004) 900-905
41. Brady J.P., Garland D., Duglas-Tabor Y., Robison Jr. W.G., Groome A., and Wawrousek E.F. Targeted disruption of the mouse alpha A-crystallin gene induces cataract and cytoplasmic inclusion bodies containing the small heat shock protein alpha B-crystallin. Proc. Natl Acad. Sci. USA 94 (1997) 884-889
42. Graw J. The genetic and molecular basis of congenital eye defects. Nature Rev. Genet. 4 (2003) 876-888
43. Graw J., Klopp N., Illig T., Preising M.N., and Lorenz B. Congenital cataract and macular hypoplasia in humans associated with a de novo mutation in CRYAA and compound heterozygous mutations in P. Graefes Arch. Clin. Expt. Ophthalmol. 244 (2006) 912-919
44. Hever A.M., Williamson K.A., and van Heyningen V. Developmental malformations of the eye: the role of PAX6, SOX2 and OTX2. Clin. Genet. 69 (2006) 459-470
45. Graw J. Congenital hereditary cataracts. Int. J. Dev. Biol. 48 (2004) 1031-1044
46. Muraoka M., Konishi M., Kikuchi-Yanoshita R., Tanaka K., Shitara N., Chong J.M., et al. p300 gene alterations in colorectal and gastric carcinomas. Oncogene 12 (1996) 1565-1569
47. Roelfsema J.H., White S.J., Ariyurek Y., Bartholdi D., Niedrist D., Papadia F., et al. Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am. J. Hum. Genet. 76 (2005) 572-580
48. Ring B.Z., Cordes S.P., Overbeek P.A., and Barsh G.S. Regulation of mouse lens fiber cell development and differentiation by the Maf gene. Development 127 (2000) 307-317
49. Ashery-Padan R., Marquardt T., Zhou X., and Gruss P. Pax6 activity in the lens primordium is required for lens formation and for correct placement of a single retina in the eye. Genes Dev. 14 (2000) 2701-2711
50. Chen Q., Ash J.D., Branton P., Fromm L., and Overbeek P.A. Inhibition of crystallin expression and induction of apoptosis by lens-specific E1A expression in transgenic mice. Oncogene 21 (2002) 1028-1037
51. Hussain M.A., and Habener J.F. Glucagon gene transcription activation mediated by synergistic interactions of pax-6 and cdx-2 with the p300 co-activator. J. Biol. Chem. 274 (1999) 28950-28957
52. Cho S., Tian Y., and Benjamin T.L. Binding of p300/CBP co-activators by polyoma large T antigen. J. Biol. Chem. 276 (2001) 33533-33539
53. Hassan A.H., Awad S., Al-Natour Z., Othman S., Mustafa F., and Rizvi T.A. Selective recognition of acetylated histones by bromodomains in transcriptional co-activators. Biochem. J. 402 (2007) 125-133
54. Vo N., and Goodman R.H. CREB-binding protein and p300 in transcriptional regulation. J. Biol. Chem. 276 (2001) 13505-13508
55. Gebuhr T.C., Kovalev G.I., Bultman S., Godfrey V., Su L., and Magnuson T. The role of Brg1, a catalytic subunit of mammalian chromatin-remodeling complexes, in T cell development. J. Expt. Med. 198 (2003) 1937-1949
56. Mantamadiotis T., Lemberger T., Bleckmann S.C., Kern H., Kretz O., Martin Villalba A., et al. Disruption of CREB function in brain leads to neurodegeneration. Nature Genet. 31 (2002) 47-54
57. Bustin S.A., and Mueller R. Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis. Clin. Sci. (Lond) 109 (2005) 365-379
58. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., and Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3 (2002) RESEARCH0034
59. Reed N.A., Oh D.J., Czymmek K.J., and Duncan M.K. An immunohistochemical method for the detection of proteins in the vertebrate lens. J. Immunol. Methods 253 (2001) 243-252
60. Stopka T., Amanatullah D.F., Papetti M., and Skoultchi A.I. PU.1 inhibits the erythroid program by binding to GATA-1 on DNA and creating a repressive chromatin structure. EMBO J. 24 (2005) 3712-3723